Autoantibody Activity in Lambert-Eaton Myasthenic Syndrome
Editorial, Lancet 1:9201988., , 1988
Plasmapheresis for Myasthenic Crisis in a Young Child
J Pediatr 110:740-742, Snead,O.C.III.,et al, 1987
Parkinson's Disease & Myasthenia Gravis:Adverse Effect of Trihexyphenidyl on Neuromuscular Transmission
Neurol 37:832-833, Ueno,S.,et al, 1987
The Eaton-Lambert (Myasthenic) Syndrome in Association with Systemic Lupus Erythematosus
Arch Neurol 43:1186-1187, Hughes,R.L.&Katirji,M.B., 1986
Worsening of Myasthenia Gravis with Timolol Maleate Eyedrops
Ann Neurol 17:211-212, Verkijk,A., 1985
Myasthenic Crisis after Intravenous Administration of Iodinated Contrast Agent
Neurol 35:1219-1220, Chagnac,Y.,et al, 1985
Plasma Exchange & Immunosuppressive Drug Treatment in the Lambert-Eaton Myasthenic Syndrome
Neurol 34:480-485, Newsom-Davis,J.,et al, 1984
The Neurotoxicity of Antibacterial Agents
Ann Int Med 101:92-104, Snavely,S.R.,et al, 1984
Myasthenia Gravis & Myasthenic Syndromes
Ann Neurol 16:519-534, Engel,A.G., 1984
Treatment of Lambert-Eaton Syndrome:3, 4-Diaminopyridine & Pyridostigmine
Neurol 34:1324-1330, Lundh,H.,et al, 1984
Beta-Adrenoreceptor Antagonists & Diplopia
Lancet 2:826-827, Weber,J.C.P., 1982
Ventilatory Failure in Myasthenia Gravis
JNNP 45:217-222, Ferguson,I.T.,et al, 1982
Plasmapheresis & Immunosuppressive Drug Therapy in the Eaton-Lambert Syndrome
Ann Neurol 11:570-575, Da,P.C.,et al, 1982
Treatment with Oral 4-aminopyridine in Disorders of Neuromuscular Transmission
Neurol 31:265-271, Murray,N.M.F.,et al, 1981
Eaton-Lambert Myasthenic Syndrome:Long-term Treatment of Three Patients with Prednisone
Ann Neurol 10:448-453, Streib,E.W.,et al, 1981
Procainamide-Induced Myasthenia-like Weakness in a Patient with Peripheral Neuropathy
Arch Neurol 38:378-379, Niakan,E.,et al, 1981
Eaton-Lambert Syndrome & Malignant Thymoma
Neurol 30:634-638, Lauritzen,M.,et al, 1980
Heat-Induced Myasthenic Crisis
Arch Neurol 37:671-672, Gutmann,L., 1980
Controversies About the Treatment of Myasthenia Gravis
JNNP 43:644-659, Rowland,L.P., 1980
Heat-Induced Myasthenic Crisis
Arch Neurol 37:671-672, Gutmann,L.,, 1980
Disorders of Neuromuscular Transmission Caused by Drugs
NEJM 301:409-413, Argov,Z.,et al, 1979
Clinical Syndromes of Myasthenia in Infancy & Childhood
Arch Neurol 35:97, Fenichel,G.M., 1978
Content of Acetylch Receptor & Antib Bound to Receptor in Myasth Gravis, Experi Autoimm Myasth Gravis, & Syndrome
Neurol 28:130, Lindstrom,J.M., 1978
Familial Neuromuscular Disease with Type 1 Fiber Hypoplasia, Tubular Aggregates, Cardiomyopathy, & Myasthenic Features
Neurol 28:1135-1140, Dobkin,B.H.,et al, 1978
4-Aminopyridine-A New Drug Tested in the Treatment of Eaton-Lambert Syndrome
JNNP 40:1109, Lundh,H.,et al, 1977
Adverse Effects of Magnesium Salt Cathartics in a Patient with the Myasthenic Syndrome (Lambert-Eaton Syndrome)
Ann Neurol 2:175, Streib,E.W., 1977
Myasthenia Gravis Assoc. with Wasp Sting
JAMA 235:2120, Brumlik,J., 1976
Important Advances in Clinical Medicine
West J Med 123:128, Mosier,J.M.,et al, 1975
The Eaton-Lambert Syndrome in Ocular Myasthenia Gravis
Arch Neurol 31:183-186, Oh,S.J., 1974
Treatment of Myasthenia II
BMJ 213, 1971 April., , 1971
Histometric Anal. of Ultra-structure of Neuromuscular Junct. in Myasthenia Gravis & in the Myasthenic Syndr
Ann N Y Acad Sci 186:46, Engel,A.,et al, 1971
Electrodiagnosis Studies in Neuromuscular Disease
NEJM 285:1244, Samaha,F., 1971
Electrodiagnosis of Neuromuscular Disease
Bull Univ Maryland School Med 56:33, Kemble,F., 1971
Diseases of Muscles-Clinical Manifestations & Differential Diagnosis
The New Physic 263, 1967, Oct., Boshes,L., 1967
Drug Therapy in Myasthenia Gravis
Mod Med 286, Sept1965., Johns,R., 1965
Myasthenic Syndrome in Patients with ALS
et al Neurol 9:627, Mulder,D.W., 1959